Deciphering cryptic proteases

Cellular and Molecular Life Sciences

Volumn 62, Issue 9, 2005, Pages 989-1002

  Liz, M A ^a,b   Sousa, M M ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Calpain like protein; Deubiquitination; Factor seven activating protease; Fibronectin; Gross cystic disease fluid protein 15 kDa; Mesotrypsin; Peroxisomal processing proteases; Transthyretin

Indexed keywords

BLOOD CLOTTING FACTOR 7 ACTIVATING PROTEASE; CALPAIN; CYSTEINE PROTEINASE; ENZYME; FIBRONECTIN; FIBRONECTIN GELATINASE; FIBRONECTIN IV COLLAGENASE; FIBRONECTIN LAMININASE; FIBRONECTINASE; GROSS CYSTIC DISEASE FLUID PROTEIN 15; MESOTRYPSIN PROTEIN; METALLOPROTEINASE; PREALBUMIN; PROTEIN; PROTEINASE; PROTEOSOMAL DEUBIQUITINATING ENZYME; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BLOOD CLOTTING; BREAST CANCER; CANCER INVASION; CATALYSIS; CELL DEATH; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME SUBSTRATE; EVOLUTION; FIBRINOLYSIS; HUMAN; NONHUMAN; PEROXISOME; PHENOTYPE; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; FIBRONECTINS; HUMANS; METALLOPROTEASES; MODELS, CHEMICAL; PEPTIDE HYDROLASES; SERINE ENDOPEPTIDASES;

EID: 18544370514     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-4544-2     Document Type: Review

References (118)

1. Tang J., James M. N. G., Hsu I. N., Jenkins J. A. and Blundell T. L. (1978) Structural evidence for gene duplication in the evolution of the acid proteases. Nature 271: 618-621
2. Miller M., Jaskolski M., Rao J. K., Leis J. and Wlodawer A. (1989) Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337: 576-579
3. Cutfield S., Marshall C., Moody P., Sullivan P. and Cutfield J. (1993) Crystallization of inhibited aspartic proteinase from Candida albicans J. Mol. Biol. 234: 1266-1269
4. Autiero M., Abrescia P. and Guardiola J. (1991) Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma. Exp. Cell Res. 197: 268-271
5. Akiyama K. and Kimura H. (1990) Isolation of a new actin-binding protein from human seminal plasma. Biochim. Biophys. Acta 1040: 206-210
6. Schenkels L. C., Schaller J., Walgreen-Weterings E., Schadee-Eestermans I. L., Veerman E. C. I. and Nieuw Amerongen A. V. (1994) Identity of human extra parotid glycoprotein (EP-GP) with secretory actin binding protein (SABP) and its biological properties. Biol. Chem. Hoppe-Seyler 375: 609-615
7. Wick M. R., Lillemoe T. J., Copland G. T., Swanson P. E., Manivel J. C. and Kiang D. T. (1989) Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum. Pathol. 20: 281-287
8. Haagensen D. E. Jr, Dilley W. G., Mazoujian G. and Wells S. A. (1990) Review of GCDFP-15. An apocrine marker protein. Ann. N. Y. Acad. Sci. 586: 161-173
9. Shiu R. P. C. and Ivasiow B. M. (1985) J. Biol. Chem. 260, 11307-11313
10. Hahnel R. and Hahnel E. (1996) Expression of the PIP/GCDFP-15 gene and survival in breast cancer. Virchows Arch. 429: 365-369
11. Caputo E., Manco G., Mandrich L. and Guardiola J. (2000) A novel aspartyl proteinase from apocrine epithelia and breast tumors. J. Biol. Chem. 275: 7935-7941.
12. Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M. et al. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704
13. Grondahl-Hansen J., Christensen, I. J., Rosenquist C., Brunner, N., Mouridsen H. T., Dano K. et al. (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 53: 2513-2521
14. Jones P. A. and DeClerck Y. A. (1980) Destruction of extracellular matrices containing glycoproteins, elastin and collagen by metastatic human tumor cells. Cancer Res. 40: 3222-3227
15. Lichtenthaler S. F. and Haass C. (2004) Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model. J. Clin. Invest. 113: 1384-1387
16. Selkoe D. J. and Schenk D. (2003) Alzheimer's disease: molecular understanding predicts myloidbased therapeutics. Annu. Rev. Pharmacol. Toxicol. 43: 545-584
17. Allinson T. M., Parkin E. T., Turner A. J. and Hooper N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74: 342-352
18. Haass C. (2004) Take five-BACE and the gammasecretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 23: 483-488
19. Vassar R. (2001) The b-secretase, BACE. A prime target for Alzheimer's disease. J. Mol. Neurosci. 17: 157-170
20. Lichtenthaler S. F., Dominguez D. I., Westmeyer G. G., Reiss K., Haass C., Saftig P. et al. (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 278: 48713-48719
21. Kitazume S., Tachida Y., Oka R., Shirotani K., Saido T. C. and Hashimoto Y. (2001) Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Proc. Natl. Acad. Sci. USA 98: 13554-13559
22. Liu K., Doms R. W. and Lee V. M. (2002) Glu11 site cleavage and N terminally truncated A beta production upon BACE overexpression. Biochemistry 41: 3128-3136
23. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P. et al. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672-674
24. Haass C. (2004) Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 23: 483-488
25. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M. et al.. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760
26. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356
27. Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and g-secretase activity. Nature 398: 513-517
28. Haass C. and Steiner H. (2002) Alzheimer disease g-secretase: a complex story of GxGD-type presenilin proteases. Trends Cell Biol. 12: 556-562
29. Weihofen A. and Martoglio B. (2003) Intramembrane-cleaving proteases: controlled liberation of functional proteins and peptides from membranes. Trends Cell Biol. 13: 71-78
30. De Strooper B. (2003) Aph-1, Pen-2 and nicastrin with presenilin generate an active g-secretase complex. Neuron 38: 9-12
31. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L. and Tandon A, (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and bAPP processing. Nature 407: 48-54
32. Francis R., McGrath G., Zhang J., Ruddy D. A., Sym M., Apfeld J. et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, g-secretase cleavage of betaAPP and presenilin protein accumulation. Dev. Cell 3: 85-97
33. Selkoe D. and Kopan R. (2003) Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 26: 565-597
34. Choi-Miura N. H., Tobe T., Sumiya J., Nakano Y., Sano Y., Mazda T. et al. (1996) Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J. Biochem. (Tokyo) 119: 1157-1165
35. Hunfeld A., Dodt J., Goy C., König H. and Seitz R. (1997) IIa-like activity in prothrombin complex concentrates. Ann. Haematol. 74: A87
36. Hunfeld A., Eischeid M. K. H., Seitz R. and Dodt J. (1998) Identification of the thrombin-like activity of PCC's. Ann. Haematol. 76: A101
37. Romisch J., Feussner A., Vermoehlen S. and Stohr H. A. ( 1999) A protease isolated from human plasma activating f actor VII independent of tissue factor. Blood Coagul. Fibrinolysis 10: 471-479
38. Kannemeier C., Feussner A., Stöhr H.A., Preissner K. T., and Römisch J. (2001) FVII- and single-chain plasminogen activator activating protease (FSAP): activation and autoactivation of the proenzyme. Eur. J. Biochem. 268: 3789-3796
39. Etscheid M., Hunfeld A., König H., Seitz R. and Dodt J. (2000) Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Biol. Chem. 381: 1223-1231
40. Morrissey J. H., Macik B. G., Neuenschwander P. F. and Comp P. C. (1993) Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81: 734-44
41. Kazama Y., Hamamoto T., Foster D. C. and Kisiel W. (1995) Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J. Biol. Chem. 270: 66-72
42. Wu Q., Yu D., Post J., Halks-Miller M., Sadler J. E. and Morser J. (1998) Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J. Clin. Invest. 101: 321-6
43. Choi-Miura N. H., Yoda M., Saito K., Takahashi K. and Tomita M. (2001) Identification of the substrates for plasma hyaluronan binding protein. Biol. Pharm. Bull. 24: 140-143
44. Kreß J., Seitz R., Dodt J. and Etscheid M. (2002) Interaction of the plasma hyaluronan-binding serine protease with extracellular matrix proteins. Ann. Haematol. 81: A47
45. Roemisch J., Vermoehlen S. F. A. and Stoehr H.A. (1999) The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 76: 292-299
46. Romisch J. (2002) Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol. Chem. 383: 1119-1124
47. Kannemeier C., Al-Fakhri N., Preissner K. T. and Kanse S. M. (2004) Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J. 18: 728-730
48. Rinderknecht H., Renner I. G., Abramson S. B. and Carmack C. (1984) Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86: 681-692
49. Wiegand U., Corbach S., Minn A., Kang, J. and Muller-Hill B. (1993) Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 136: 167-175
50. Chen J.-M. and Ferec C. (2003) Trypsinogen genes: evolution. In: Nature Encyclopedia of the Human Genome, vol. 5, pp. 645-650, Cooper D. N., ed., Nature Publishing Group, London
51. Nyaruhucha C. N. M., Kito M. and Fukuoka S. I. (1997) Identification and expression of the cDNA-encoding human mesotrypsin(ogen), an isoform of trypsin with inhibitor resistance. J. Biol. Chem. 272: 10573-10578
52. Katona G., Berglund G. I., Hajdu J., Graf L. and Szilagyi L. (2002) Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. J. Mol. Biol. 315: 1209-1218
53. Szmola R., Kukor Z. and Sahin-Toth M. (2003) Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J. Biol. Chem. 278: 48580-48589
54. Blake C. C. F., Geisow M. J. and Oatley S. J. (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121: 339-356
55. Dickson P. W., Howlett G. J. and Schreiber G. (1985) Rat transthyretin (prealbumin). Molecular cloning, nucleotide sequence, and gene expression in liver and brain. J. Biol. Chem. 60: 8214-8219
56. Monaco H. E. (2000) The transthyretin-retinol-binding protein complex. Biochim. Biophys. Acta 1482: 65-72
57. Sousa M. M., Berglund L. and Saraiva M. J. (2000) Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res. 41: 58-65
58. Liz M. A., Faro C. J., Saraiva M. J. and Sousa M. M. (2004) Transthyretin, a new cryptic protease. J. Biol. Chem. 279: 21431-21438
59. Dodson G. and Wlodawer A. (1998) Catalytic triads and their relatives. Trends Biochem. Sci. 23: 347-352
60. Birghan C., Mundt E. and Gorbalenya A. E. (2000) A non-canonical Ion proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J. 19: 114-123
61. Gorshkova I. N., Liadaki K., Gursky O., Atkinson D. and Zannis V. I. (2000) Probing the lipid-free structure and stability of apolipoprotein A-I by mutation. Biochemistry 39: 15910-15919
62. Panagotopulos S. E., Witting S. R., Horace E. M., Hui David Y. and Maiorano J. N. (2002) The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1. J. Biol. Chem. 277: 39477-39484
63. Lee M., Kovanen P. T., Tedeschi G., Oungre E., Franceschini G. and Calabresi L. (2003) Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux. J. Lipid Res. 44: 539-546
64. de Sousa M. M., Vital C., Ostler D., Fernandes R., Pouget-Abadie J., Carles D. et al. (2000) Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am. J. Pathol. 156: 1911-1917
65. Huang Y. and Wang K. K. (2001) The calpain family and human disease. Trends Mol. Med. 7: 355-362
66. Lid S. E., Gruis D., Jung R., Lorentzen J. A., Ananiev E., Chamberlin M. et al. (2002) The defective kernel 1 (dek1) gene required for aleurone cell development in the endosperm of maize grains encodes a membrane protein of the calpain gene superfamily. Proc. Natl. Acad. Sci. USA 99: 5460-5465
67. Barnes T. M. and Hodgkin J. (1996) The tra-3 sex determination gene of Caenorhabditis elegans encodes a member of the calpain regulatory protease family. EMBO J. 15: 4477-4484
68. Arthur J. S., Elce J. S., Hegadorn C., Williams K. and Greer P. A. (2000) Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell. Biol. 20: 4474-4481
69. Huang X., Czerwinski E. and Mellgren R. L. (2003) Purification and properties of the Dictyostelium calpain-like protein, Cpl. Biochemistry 42: 1789-1795
70. 2+-regulated phospholipid-binding domain. Biochem. Biophys. Res. Commun. 280: 1333-1339
71. Metrione R. M. (1986) On the relationship of calpains to the papain family. Trends Biochem. Sci. 11: 117-118
72. Hertz-Fowler C., Ersfeld K. and Gull K. (2001) CAP5.5, a life-cycle-regulated, cytoskeleton-associated protein is a member of a novel family of calpain-related proteins in Trypanosoma brucei. Mol. Biochem. Parasitol. 116: 25-34
73. Lynn S., Evans J. C., White C., Frayling T. M., Hattersley A. T., Turnbull D. M. et al. (2002) Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51: 247-250
74. Solomon M., Belenghi B., Delledonne M., Menachem E. and Levine A. (1999) The involvement of cysteine proteases and protease inhibitor genes in the regulation of programmed cell death in plants. Plant Cell 11: 431-444
75. Korthout H. A. A. J., Berecki G., Bruin W., van Duijn B. and Wang M. (2000) The presence and subcellular localization of caspase 3-like proteinases in plant cells. FEBS Lett. 475: 139-144
76. Lam E. and del Pozo O. (2000) Caspase-like protease involvement in the control of plant cell death. Plant Mol. Biol. 44: 417-428
77. Madeo F., Herker E., Maldener C., Wissing S., Lächelt S., Herlan M. et al. (2002) A caspases-related protease regulates apoptosis in yeast. Mol. Cell 9: 911-917
78. Segovia M., Haramaty L., Berges J. A. and Falkowski P. G. (2003) Cell death in the unicellular chlorophyte Dunaliella tertiolecta. A hypothesis on the evolution of apoptosis in higher plants and metazoans. Plant Physiol. 13: 99-105
79. Aravind L., Dixit V. M. and Koonin E. V. (2001) Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291: 1279-1286
80. Gould S. J., Keller G. A., Hosken N., Wilkinson J. and Subramani S. (1989) A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108: 1657-1664
81. Jansen G. A., Ofman R., Ferdinandusse S., Ijlst L., Muijsers A. O., Skjeldal O. H. et al. (1997) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat. Genet. 17: 190-193
82. Swinkels B. W., Gould S. J., Bodnar A. G., Rachubinski R. A. and Subramani S. (1991) A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10: 3255-3262
83. Rachubinski R. A. and Subramani S. (1995) How proteins penetrate peroxisomes. Cell 83: 525-528
84. Gray R. W., Arsenis C. and Jeffay H. (1970) Neutral protease activity associated with the rat liver peroxisomal fraction. Biochim. Biophys. Acta 222: 627-636
85. Komov V. P., Strelkova M. A. and Makeeva A. L. (1988) Neutral proteinase in peroxisomes from rat liver cells. Biokhimiia 53: 1532-1538
86. Authier F., Bergeron J. J. M., Ou W.-J., Rachubinski R. A., Posner B. I. and Walton P. A. (1995) Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc. Natl. Acad. Sci. USA 92: 3859-3863
87. Biermann J. and van den Bosch H. (1999) In vitro processing of the human alkyl-dihydroxyacetonephosphate synthase precursor. Arch. Biochem. Biophys. 368: 139-146
88. Kato A., Hayashi M., Kondo M. and Nishimura M. (1996) Targeting and processing of a chimeric protein with the N-terminal presequence of the precursor to glyoxysomal citrate synthase. Plant Cell 8: 1601-161
89. Voges D., Zwickl P. and Baumeister W. (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68: 1015-1068
90. Zwickl P., Baumeister W. and Steven A. (2000) Dis-assembly lines: the proteasome and related ATPase-assisted proteases. Curr. Opin. Struct. Biol. 10: 242-250
91. Glickman M. H. and Maytal V. (2002) Regulating the 26S proteasome. Curr. Top. Microbiol. Immunol. 268: 43-72
92. Glickman M. H. (2000) Getting in and out of the proteasome. Semin. Cell Dev. Biol. 11: 149-158
93. Glickman M. H., Rubin D. M., Coux O., Wefes I., Pfeifer G., Cjeka Z. et al. (1998) A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94: 615-623
94. Pickart C. M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533
95. Weissman A. M. (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2: 169-178
96. Glickman M. H. and Ciechanover A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428
97. Wing S. S. (2003) Deubiquitinating enzymes - the importance of driving in reverse along the ubiquitin-proteasome pathway. Int. J. Biochem. Cell Biol. 35: 590-605
98. Kim J. H., Park K. C., Chung S. S., Bang O. and Chung C. H. (2003) Deubiquitinating enzymes as cellular regulators. Biochem. (Tokyo). 134: 9-18
99. Baek K. H. (2003) Conjugation and deconjugation of ubiquitin regulating the destiny of proteins. Exp. Mol. Med. 35: 1-7
100. Guterman A. and Glickman M. H. (2004) Deubiquitinating enzymes are IN/(trinsic to proteasome function). Curr. Protein Pept. Sci. 5: 201-211
101. Wilkinson K. D. (2000) Ubiquitination and deubiquitination: targeting of proteins for degradation by the protease. Semin. Cell Dev. Biol. 11: 141-148
102. Yao T. and Cohen R. E. (2002) A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419: 403-407
103. Verma R., Aravind L., Oania R., McDonald W. H., Yates J. R., Koonin E. V. et al. (2002) Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298: 611-615
104. Akiyama S. K. and Yamada KM (1987) Fibronectin. Adv. Enzymol. 57: 1-57
105. Clark R. A. and Colvin R. B. ( 1985) Wound repair. In: Plasma Fibronectin: Structure and Function, pp. 197-263, McDonagh J. (ed.), New York
106. Humphries M. J. (1993) Fibronectin and cancer: rationales for the use of antiadhesives in cancer treatment. Semin. Cancer Biol. 4: 293-299
107. Beezhold D. H. and Personius C. (1992) Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes. J. Leukoc. Biol. 51: 59-64
108. De Petro G., Barlati S., Vartio T. and Vaheri A. (1983) Transformation-enhancing activity in plasma of tumor patients: relationship with fibronectin fragments. Int. J. Cancer 15: 157-162
109. Tremble P. M., Damsky C. H. and Werb Z. (1992) Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. Matrix Suppl. 1: 212-214
110. Emod I., Lafaye P., Planchenault T., Lambert Vidmar S., Imhoff J. M. and Keil-Dlouha V. (1990) Potential proteolytic activity of fibronectin: fibronectin laminase and its substrate specificity. Biol. Chem. Hoppe Seyler 371: 129-135
111. Planchenault T., Lambert Vidmar S., Imhoff J. M., Blondeau X., Emod I., Lottspeich F. et al. (1990) Potential proteolytic activity of human plasma fibronectin: fibronectin gelatinase. Biol. Chem. Hoppe Seyler 371: 117-128
112. Lambert Vidmar S., Lottspeich F., Emod I., Planchenault T. and Keil-Dlouha V. (1991) Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur. J. Biochem. 201: 71-77
113. Lambert Vidmar S., Lottspeich F., Emod I., Imhoff J. M. and Keil-Dlouha V. (1991) Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase. Eur. J. Biochem. 201: 79-84
114. Schnepel J., Unger J. and Tschesche H. (2001) Recombinant cryptic human fibronectinase cleaves actin and myosin: substrate specificity and possible role in muscular dystrophy. Biol Chem. 382: 1707-1714
115. Gopalan P., Dufresne M. J. and Warner A. H. (1987) Thiol protease and cathepsin D activities in selected tissues and cultured cells from normal and dystrophic mice. Can. J. Physiol. Pharmacol. 65: 124-129
116. Unger J. and Tschesche H. (1999) The proteolytic activity and cleavage specificity of fibronectin-gelatinase and fibronectin-lamininase. J. Protein. Chem. 18: 403-411
117. Schnepel J. and Tschesche H. (2000) The proteolytic activity of the recombinant cryptic human fibronectin type IV collagenase from E. coli expression. J. Protein Chem. 19: 685-692
118. Xie D. L., Meyers R. and Homandberg G. A. (1992) Fibronectin fragments in osteoarthritic synovial fluid. J. Rheumatol. 19: 1448-1452